Alkermes Completes Patient Enrollment in Clinical Trial of Alcoholism Drug.
Business Wire › September 27, 2000
Linked as:
Extract
Alkermes Completes Patient Enrollment in Clinical Trial of Alcoholism Drug.
Business/Technology Editors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sept. 27, 2000 Medisorb Naltrexone, a new injectable sustained release formulation of naltrexone, tested in 42 subject study Alkermes, Inc., (NASDAQ: ALKS) today announced the completion ...See the full content of this document
Sponsored links
